Business Wire

Highly positive FM71 Phase 3 study results with all primary and secondary endpoints achieved, MED3000 remains on track to submit for FDA marketing authorization

MED3000 achieved the FDA agreed criteria for proving a rapid onset of action at 10 minutes where patients noticed an erection whereas tadalafil did not achieve the agreed criteria. MED3000 also showed ...
Yahoo

There's a New Over-the-Counter ED Drug. Should You Be Taking It?

WHEN YOU'RE DEALING with erectile dysfunction, you usually have to make an appointment with your doctor to get treated. But, soon, you'll be able to pick up medication at your local pharmacy without a ...
London South East

Application to the US FDA for MED3000

Futura Announces Completion of its De Novo Medical Device Application to the US FDA for its Breakthrough Topical Gel Formulation MED3000 for Erectile Dysfunction Futura Medical plc (AIM: FUM), a ...